Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Type I fimbriae are the main adhesive organelles of uropathogenic (UPEC), consisting of four different subunits. Their component with the most important role in establishing bacterial infections is the FimH adhesin located at the fimbrial tip. This two-domain protein mediates adhesion to host epithelial cells through interaction with terminal mannoses on epithelial glycoproteins. Here, we propose that the amyloidogenic potential of FimH can be exploited for the development of therapeutic agents against Urinary Tract Infections (UTIs). Aggregation-prone regions (APRs) were identified via computational methods, and peptide-analogues corresponding to FimH lectin domain APRs were chemically synthesized and studied with the aid of both biophysical experimental techniques and molecular dynamic simulations. Our findings indicate that these peptide-analogues offer a promising set of antimicrobial candidate molecules since they can either interfere with the folding process of FimH or compete for the mannose-binding pocket.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058141PMC
http://dx.doi.org/10.3390/pharmaceutics15031018DOI Listing

Publication Analysis

Top Keywords

fimh
5
bacterial lectin
4
lectin fimh
4
fimh aggregation
4
aggregation hot-spots
4
hot-spots alternative
4
alternative strategy
4
strategy uropathogenic
4
uropathogenic type
4
type fimbriae
4

Similar Publications

Background And Aim: The global rise of multidrug-resistant (MDR) poses a serious threat to human and animal health. Close proximity between humans and domestic animals may facilitate zoonotic transmission of MDR strains, underscoring the need for integrated surveillance strategies. This study aimed to investigate the genetic diversity, resistance mechanisms, and virulence gene profiles of isolates from domestic animals and humans in Mato Grosso, Brazil, within the One Health framework.

View Article and Find Full Text PDF

Aims: Klebsiella pneumoniae (K. pneumoniae), a multidrug-resistant opportunistic pathogen implicated in pneumonia and nosocomial infections, employs biofilm formation to evade antimicrobial therapies.

Methods: This study investigates how propolis and its key bioactive constituents-naringenin, taxifolin, syringic acid, and gallic acid-disrupt biofilm development and stability in K.

View Article and Find Full Text PDF

The rise of multidrug-resistant bacterial infections necessitates the discovery of novel antimicrobial strategies. Here, we show that protein design provides a generalizable means of generating new antimicrobials by neutralizing the function of bacterial adhesins, which are virulence factors critical in host-pathogen interactions. We designed high-affinity miniprotein binders to FimH and Abp1D/Abp2D chaperone usher pili adhesins from uropathogenic and , respectively, which are implicated in mediating both uncomplicated and catheter-associated urinary tract infections (UTI) responsible for significant morbidity and mortality worldwide.

View Article and Find Full Text PDF

Objectives: Urinary tract infections caused by multidrug-resistant uropathogenic (UPEC) strains limit therapeutic options and pose a serious threat to global health. This study aimed to analyze the phylogenetic distribution and virulence genes of multidrug resistant (MDR) UPEC strains and their associated risk factors.

Methods: UPEC isolates were subjected to phylogenetic and virulence genotyping using conventional and multiplex polymerase chain reaction methods.

View Article and Find Full Text PDF

Background And Objectives: Klebsiella pneumoniae is a multidrug-resistant pathogen implicated in severe community- and hospital-acquired infections such as bacteremia, urinary tract infections, sepsis, and pneumonia. Biofilm formation, driven by extracellular polymeric substances (EPS), enhances its persistence and resistance to antibiotics. This study evaluated the anti-biofilm, antibacterial, and quorum-quenching activities of a novel α-amylase B.

View Article and Find Full Text PDF